Sileo is the first and only FDA-approved medication specifically indicated for the treatment of noise aversion in dogs. Manufactured by Zoetis, Sileo contains dexmedetomidine in a unique oromucosal gel formulation that is applied between the dog’s cheek and gum. Unlike oral medications that must be absorbed through the GI tract, Sileo is absorbed directly through the oral mucosa, providing faster and more predictable onset of action. It calms dogs during noise events such as fireworks, thunderstorms, and other loud disturbances without deeply sedating them at appropriate doses.
What Is Sileo Used For?
Sileo is specifically indicated for:
- Noise aversion in dogs — the FDA-approved indication
- Fireworks anxiety — one of the most common uses, particularly around July 4th and New Year’s Eve
- Thunderstorm phobia — fear and anxiety during storms
- Other noise events — gunshots, construction noise, sirens, or any distressing loud sounds
Sileo is designed for acute, event-based use (given before or at the onset of a noise event), not for daily maintenance therapy. For dogs with chronic anxiety disorders, daily medications like fluoxetine or clomipramine may be more appropriate, though Sileo can be used as needed alongside daily behavioral medications.
How Does Sileo Work?
Dexmedetomidine is an alpha-2 adrenoceptor agonist. By activating alpha-2 receptors in the brain, it reduces norepinephrine release, which is the neurotransmitter responsible for the “fight or flight” response. This produces a calming effect that reduces anxiety and fear responses to noise without causing the deep sedation seen at higher doses used in veterinary anesthesia.
The oromucosal gel formulation is applied between the cheek and gum, where it is absorbed directly through the mucous membranes into the bloodstream. This transmucosal absorption provides onset of effect within approximately 30 minutes, which is faster and more reliable than oral medications that must survive the acidic stomach environment and first-pass liver metabolism.
Dosage
Sileo is dosed based on body weight using the pre-loaded multidose syringe. Your veterinarian will prescribe the appropriate dose and demonstrate how to use the syringe.
| Dog’s Weight | Dose (gel volume) | Ring Stop Setting |
|---|---|---|
| 4.4-12 lbs (2-5.5 kg) | 0.25 mL | Between rings 1 and 2 |
| 12.1-22 lbs (5.5-10 kg) | 0.5 mL | Between rings 2 and 3 |
| 22.1-44 lbs (10-20 kg) | 1.0 mL | Between rings 3 and 4 |
| 44.1-88 lbs (20-40 kg) | 1.5 mL | Between rings 4 and 5 |
| 88.1-176 lbs (40-80 kg) | 2.0 mL | Between rings 5 and 6 |
- Apply 30 minutes to 1 hour before the anticipated noise event when possible
- Can also be applied at the onset of noise or signs of anxiety
- A second dose may be given after 2 hours if the noise event continues and the dog shows signs of anxiety
- Maximum 5 doses per event; do not exceed this in a 24-hour period
How to Give Sileo to Your Dog
- Set the ring stop on the dosing syringe to the number of dots corresponding to your dog’s weight range.
- Place the syringe tip between the cheek and gum (not on top of the tongue).
- Push the plunger to deposit the gel between the cheek and gum.
- The dog should not swallow the gel — it is designed to be absorbed through the mucous membranes. If the dog swallows the gel, it will be less effective.
- Do not allow your dog to eat or drink for 15-20 minutes after application, as this can wash away the gel before absorption.
- Wear disposable gloves when handling Sileo. Dexmedetomidine can be absorbed through human skin and mucous membranes and can cause drowsiness and blood pressure changes.
- If gel contacts your skin, wash immediately with copious amounts of water.
- After use, replace the cap securely on the syringe.
Side Effects
| Common Side Effects | Serious Side Effects (Contact Your Vet) |
|---|---|
| Mild sedation (at appropriate doses) | Excessive sedation or inability to rouse |
| Pale gums (temporary) | Very slow heart rate (bradycardia) |
| Lowered body temperature (mild) | Collapse or fainting |
| Mild decrease in blood pressure | Difficulty breathing |
| Slight decrease in heart rate | Vomiting |
At the labeled dose for noise aversion, Sileo provides a calming effect without deep sedation. Dogs should remain able to walk, respond to their name, and function normally, though they may appear more relaxed than usual. If your dog becomes deeply sedated or unresponsive, contact your veterinarian.
Drug Interactions
- Other sedatives or CNS depressants (trazodone, gabapentin, acepromazine): Additive sedation and cardiovascular depression. Use with caution and under veterinary guidance.
- Other alpha-2 agonists (clonidine): Do not combine.
- Opioids: Additive sedation and cardiovascular effects.
- Atipamezole: This is the specific reversal agent for dexmedetomidine and can be used in cases of overdose or excessive sedation.
Contraindications
- Known hypersensitivity to dexmedetomidine
- Dogs with severe cardiovascular disease (heart block, severe bradycardia, low blood pressure)
- Dogs with severe liver or kidney disease
- Dogs with respiratory disease that may be worsened by sedation
- Pregnant, lactating, or breeding dogs — safety not established
- Puppies under 16 weeks of age or weighing less than 4.4 lbs (2 kg)
Storage
- Store at controlled room temperature, 68-77degF (20-25degC).
- Replace cap securely after each use.
- Each syringe contains enough gel for multiple doses; discard after use or according to label instructions.
- Keep out of reach of children and pets.
Cost & Availability
Sileo is a prescription-only medication available through veterinary clinics.
- Approximate cost: $30-$50 per multidose syringe (provides multiple doses per noise event)
- Available only through veterinary clinics — not typically stocked at human pharmacies
- No generic version is currently available
- Compared to as-needed use of trazodone or alprazolam, Sileo offers a specifically engineered delivery system for noise events
Frequently Asked Questions
How is Sileo different from other anxiety medications? Sileo is the only medication specifically FDA-approved for noise aversion in dogs. Its oromucosal delivery system provides rapid, predictable absorption without needing to swallow a pill. Compared to oral trazodone or alprazolam, Sileo offers a purpose-designed solution with a unique delivery method. However, for dogs with generalized anxiety or multiple anxiety triggers, daily medications may be more appropriate.
Can I use Sileo for my dog’s separation anxiety? Sileo is not indicated for separation anxiety. It is approved specifically for noise aversion (acute, event-based anxiety triggered by loud sounds). For separation anxiety, daily medications like fluoxetine (Reconcile) or clomipramine (Clomicalm) are FDA-approved options.
Do I need to wear gloves when applying Sileo? Yes. Dexmedetomidine can be absorbed through human skin and mucous membranes. Accidental exposure can cause drowsiness, reduced blood pressure, and slowed heart rate in people. If you accidentally get Sileo on your skin, wash the area immediately with water. If accidentally ingested or if symptoms occur, seek medical attention.
Can Sileo be used with other behavioral medications? Some veterinarians use Sileo in combination with other anxiety medications (trazodone, gabapentin) for severe noise phobia, but this should only be done under veterinary guidance due to the risk of additive sedation and cardiovascular effects. Always discuss your dog’s complete medication list with your veterinarian.
Sources & References
- FDA - Sileo (Dexmedetomidine) Approval
- DailyMed - Sileo Label
- Zoetis - Sileo Product Information
- VCA Hospitals - Noise Aversion in Dogs
- Merck Veterinary Manual - Behavioral Pharmacotherapy
Verification Notes
Sileo’s FDA approval for canine noise aversion is confirmed as TRUE in the fact-check report (Claim C7). The research corpus describes it as “first FDA-approved for noise aversion” with “Transmucosal gel applied between cheek and gums; works in ~30 min.” Pricing ($30-50 per syringe for as-needed use) is consistent with the research data. The veterinary-specific nature of the oromucosal gel formulation is verified.